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RESEARCH ARTICLE
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Abstract
Based on structural similarities and equine administration experiments, Barbarin,
5-phenyl-2-oxazolidinethione from Brassicaceae plants, is a possible source of equine
urinary identifications of aminorex, (R,S)-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine,
an amphetamine-related US Drug Enforcement Administration (DEA) controlled
substance considered illegal in sport horses. We now report the synthesis and
certification of d5-barbarin to facilitate research on the relationship between plant
barbarin and such aminorex identifications. D5-barbarin synthesis commenced with
production

of

d5-2-oxo-2-phenylacetaldehyde

oxime

(d5-oxime)

from

d5-

acetophenone via butylnitrite in an ethoxide/ethanol solution. This d5-oxime was
then reduced with lithium aluminum hydride (LiAlH4) to produce the corresponding
d5-2-amino-1-phenylethan-1-ol (d5-phenylethanolamine). Final ring closure of the d5phenylethanolamine was performed by the addition of carbon disulfide (CS2) with
pyridine. The reaction product was purified by recrystallization and presented as a
stable white crystalline powder. Proton NMR spectroscopy revealed a triplet at
5.88 ppm for one proton, a double doublet at 3.71 ppm for one proton, and double
doublet at 4.11 ppm for one proton, confirming d5-barbarin as the product. Further
characterization by high resolution mass spectrometry supports the successful
synthesis of d5-barbarin. Purity of the recrystallized product was ascertained by High
Performance Liquid Chromatography (HPLC) to be greater than 98%. Together, we
have developed the synthesis and full characterization of d5-barbarin for use as an
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internal standard in barbarin-related and equine forensic research.
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levamisole,6,7 Teale and Biddle3 proposed that the likely source of

I N T RO DU CT I O N

|

their aminorex identifications was glucobarbarin, a barbarin precursor
Based

on

structural

similarities

and

equine

administration

found in Brassicaceae plants.

experiments, barbarin, 5-phenyl-2-oxazolidinethione from Brassica-

Plants of the genus Barbarea Brassicaceae family contain

ceae plants, is a possible source of aminorex (R,S)-5-phenyl-4,5-dihy-

glucobarbarin, a barbarin precursor. Structural damage in these plants

dro-1,3-oxazol-2-amine, (Figure 1) identifications in race and sport

triggers hydrolysis of glucobarbarin by myrosinase to an intermediate

horse urines. Aminorex is an amphetamine-related (Hofmaier et al,

which spontaneously cyclizes to barbarin, Figure 2, which then

20131) US Drug Enforcement Administration (DEA) controlled

functions as an insect repellant or attractant.8 As set forth above,

substance considered illegal in racing and sport horses. Aminorex is

barbarin is related structurally to aminorex, and consumption of

also an Association of Racing Commissioners International [ARCI]

Brassicaceae plant fragments in equine feed is therefore a possible

Class 1, Penalty class A foreign substance, so identifications of

source of unexplained aminorex identifications, as demonstrated in

aminorex in equine samples can give rise to significant penalties for

our recently published research.9

horsemen (ARCI Uniform Classification Guidelines for Foreign

While this equine administration research9 links consumption

Substances January 2018 (V.13.4),2 the suggested penalties being in

of the Brassicaceae plant Barbarea vulgaris to urinary aminorex

the order of a 1-year suspension and a $10,000 fine.

identifications, it does not unequivocally identify barbarin as the

This relationship between plant barbarin and equine urinary ami-

proximate chemical source of these identifications. To address this

norex identifications was first suggested by Teale and Biddle (2018),3

matter, we have streamlined the synthesis, purified, and characterized

who had identified aminorex in English sport horse plasma samples

d5-barbarin, the availability of which will allow more definitive

with no known exposure to aminorex or levamisole, levamisole being

identification of the relationship between plant barbarin and equine

an equine anthelmintic, and immune stimulant known to metabolize

consumption of such plant material being associated with equine

to aminorex.4,5 Reviewing their aminorex identifications, the absence

aminorex identifications. D5-barbarin was synthesized by a variant of

of any known sources of aminorex, the presence of a number of small

previously described barbarin synthesis methods10–14 as follows.

plant-related molecules in their equine plasma samples and the lack of
presence

of

pemoline

or

rexamino,

known

metabolites

of

2
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D5-BARBARIN SYNTHESIS

Synthesis of d5-barbarin was achieved in three steps, Figure 3 below,
a modification of our previously described synthetic methodology.
Briefly, d5-acetophenone was subjected to a butylnitrite-mediated
F I G U R E 1 Structures of aminorex and barbarin. Aminorex, (R,S)5-phenyl-4,5-dihydro-1,3-oxazol-2-amine, molar mass, 162.19 g/mol
(left), and barbarin, 5-phenyl-2-oxazolidinethione, molar mass,
179.24 g/mol (right) [Colour figure can be viewed at
wileyonlinelibrary.com]

transformation to d5-2-oxo-2-phenylacetaldehyde oxime (d5-oxime) in
good yield. Reduction of d5-oxime using LiAlH4 afforded the hydroxyamine,

d5-2-amino-1-phenylethan-1-ol

(d5-phenylethanolamine).

The final ring closure step to form d5-barbarin is an atom-economy
transformation that utilizes carbon disulfide in pyridine as described in

F I G U R E 2 In plants, glucobarbarin is
hydrolyzed by the enzyme myrosinase to the
isothiocyanate intermediate, above center, which
spontaneously cyclizes to barbarin.

F I G U R E 3 Overall reaction scheme for synthesis of d5-barbarin, starting with d5-acetophenone, butylnitrite, and sodium ethoxide, yielding
d5-oxime, followed by reduction with lithium aluminum hydride to give d5-phenylethanolamine, which was then reacted with carbon disulfide in
the presence of pyridine to yield d5-barbarin.

3
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our previous reports on the synthesis of unlabeled barbarin.13,14

a reaction vessel. To this solution, d5-acetophenone (1 g, 8.0 mmol)

Details on the synthesis are provided in the supporting information.

dissolved in 10 ml of ethanol was added dropwise over 30 min at 0 C,
and the reaction warmed to room temperature overnight. The precipi-

3

|

EXPERIMENTAL

tate formed was filtered, washed with ether, dissolved in a minimum
quantity of water acidified with glacial acetic acid, and the resulting

Synthesis of d5-oxime: Butyl nitrite (0.96 ml, 8.2 mmol) in ice-cold

off-white solid filtered and recrystallized from ethanol (0.56 g, 45%

ethanol (50 ml) was added to sodium ethoxide (0.565 g, 8.2 mmol) in

yield). The recovered d5-oxime material was characterized by 1H NMR

FIGURE 4

Proton NMR of d5-barbarin. * = water [Colour figure can be viewed at wileyonlinelibrary.com]

F I G U R E 5 Mass spectrum of d5-barbarin
by high-resolution electrospray ionizationmass spectrometry [M + H] + for
C9H4D5NOS, m/z 185.0795, as above,
matching an expected value of 185.0791
[Colour figure can be viewed at
wileyonlinelibrary.com]
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and mass spectrometry as appropriate for d5-oxime, m/z 154.0791,

following method: Flow rate: 1 ml/min; λ = 280 nm; eluent A = DI

HNMR (DMSO-d6, 400 MHz) δ (ppm): 1H (s, 8.0, 1H), as in Figure S1

water with 0.1% trifluoroacetic acid; eluent B = acetonitrile with

1

in the supporting information.

0.05% formic acid; solvent gradient: 0–16 min (0:100 H2O: ACN),
16 min until end of run (100:0 H2O: ACN).

Synthesis of d5-phenylethanolamine: To a round bottomed flask
charged with argon and fitted with a dropping funnel and stir bar was
added LiAlH4 (0.115 g, 3.04 mmol 4 equivalent) in anhydrous ether

3.1

|

D5-barbarin characterization

(30 ml) and the LiAlH4/ether slurry was stirred at 0 C. Then, d5-oxime
(0.117 g, 0.76 mmol 1 eq), dissolved in anhydrous ether (10 ml), was

The white crystalline material obtained following purification was

added dropwise, and the mixture stirred and refluxed for 10 h. Excess

characterized as follows: Analysis by proton nuclear mass resonance

hydride was hydrolyzed by water and ether and the white precipitate

yielded the following, 1H NMR (CDCl3, 400 MHz) δ (ppm): 5.88 (t, 1H,

formed filtered off. The ethereal filtrate was dried over anhydrous

J = 8 Hz), 4.13 (t, 1H, J = 8 Hz), 3.71 (dd, 1H, J = 4 Hz, 8 Hz), 1.25

Na2SO4, concentrated to yield a yellow solid (75 mg, 70% yield). The

(s, 1H) as shown in Figure 4. High-resolution mass spectrometry

recovered d5-phenylethanolamine was characterized by

1

H NMR

presented [M + H]+ for C9H4D5NOS at m/z 185.0795, as in Figure 5,

(CDCl3, 400 MHz) δ (ppm): 4.87 (t,1H), 3.10 (dd, 1H) and 2.85 (dd,1H),

and mass spectral product ions (Figure 6) could be interpreted as

4.80 (1H, OH), 1.98 (2H, NH2) as in Figure S2 in the supporting

listed in Table 1. Isotopic abundance analysis also provided excellent

information, HRMS: Found m/z: 142.115. Calculated: 142.12.

agreement with expected m/z values and expected relative
abundances in high-resolution mass spectrometry experiments

Synthesis of d5-barbarin: d5- phenylethanolamine (0.075 g, 1 eq) in

(supporting information Table S2). Based on NMR, HRMS, and HPLC,

THF (20 ml) was added to excess carbon disulfide (1 ml) in the

we have characterized the final product as d5-barbarin for use in

presence of 1 equivalent of pyridine. The mixture was refluxed at

barbarin-related research.

70 C for 16 h and the reaction monitored by TLC. Upon completion,
the reaction was cooled to room temperature, concentrated, and
washed with 1 N HCl, water, and the aqueous layer extracted with

4
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DI SCU SSION

DCM. The resulting organic layers were combined, dried with Na2SO4,
and the yellow solid recrystallized twice from DCM/hexane solvent

D5-barbarin synthesis commenced with production of d5-oxime from

system (45 mg, 50% yield). H NMR (CDCl3, 400 MHz) δ (ppm): 5.88

d5-acetophenone via butylnitrite in an ethoxide/ethanol solution as

(t, 1H, J = 8 Hz), 4.13 (t, 1H, J = 8 Hz), 3.71 (dd, 1H, J = 4 Hz, 8 Hz),

described by Norman et al. in 1962.10 This oxime product was

1.25 (s, 1H) (Figure 4), and HRMS: Found (m/z): [M + H]+ for

obtained in good yield and reduced with lithium aluminum hydride,11

C9H4D5NOS 185.0795. Calculated: 185.0791 (Figure 5). Purity was

producing the corresponding d5-phenylethanolamine, again in good

determined to be >98% by RP-HPLC: Rf = 4.58 min using the

yield. Final ring closure of the d5-phenylethanolamine was performed

1

by addition of carbon disulfide in the presence of pyridine, as previously described.13,14 The d5-barbarin reaction product was presented
as a stable white crystalline powder, which was obtained in sufficient
yield, purified by recrystallization, and chemically characterized as
d5-barbarin by proton NMR, HPLC, and ESI-mass spectrometry and
prepared for use as an internal standard in barbarin-related research.
The research requirement for d5-barbarin comes from the apparent ability of Brassicaceae plants consumed by horses at pasture in
Kentucky, New York, and elsewhere to give rise to low-concentration
urinary identifications of aminorex, a US DEA schedule 1 controlled
F I G U R E 6 ESI-MS of d5-barbarin [Colour figure can be viewed at
wileyonlinelibrary.com]

substance prohibited in racing and sport horses. A previous unexpected source of aminorex identifications was levamisole, a veterinary

Product ion seen in
d5-barbarin, m/z

Interpretation

Corresponding product
ion in d0-barbarin, m/za

125

[M + H]+

120

+

151

[M + H]

185

[M + H]+

carbon oxide sulfide (S=C=O)
hydrogen sulfide (SH2)

146
180

Note: The corresponding product ions from nondeuterated d0-barbarin are listed for comparison.
a
Extracted from ESI-MS of d0-barbarin. See Figure S4 in the supporting information.

T A B L E 1 Interpretation of
d5-barbarin ESI-MS mass spectral
product ions

5
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anthelmintic, and immune stimulant at one time not infrequently
prescribed in racing and sport horses. Identification of levamisole
administration as a source of aminorex identifications4 led to a
marked reduction in the number of aminorex identifications in racing
horses but not to their complete elimination, as noted by Teale and
Biddle in 2018.3

5
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C O N CL U S I O N S

In closing, d5-barbarin has now been synthesized, purified, and
characterized. D5-barbarin presents as a stable white crystalline
substance and is available as a stable isotope internal standard for
analytical, forensic, or toxicological research. Additionally, if required,
this d5-barbarin is available in larger quantities such as may be
required for in vitro or in vivo research on the role of barbarin and
related plant substances relevant to possible plant sources of
aminorex or plant precursors of aminorex giving rise to aminorex
identifications in equine drug testing samples.
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